Antidepressants are one of the main pollutants in the aquatic environment. They are being widely studied due to their widespread use, possible health effects, and partial removal from wastewater treatment plants by conventional methods. Photocatalysis is an effective and ecologically beneficial method in wastewater treatment. In the present study, the photocatalytic degradation of sertraline hydrochloride (SERT) in water using nano-sized zinc oxide (ZnO-NPs) was investigated. The ZnO-NPs were synthesized from zinc gluconate as a precursor by the sol–gel method. The crystal structure, morphology, surface charge, and textural properties were characterized by X-ray diffraction, scanning electron microscopy, energy-dispersive X-ray analyses, transmission electron microscopy, Fourier-transform infrared spectroscopy, zeta potential, and N2 adsorption–desorption measurements. The removal of SERT in water was explored by different processes: H2O2/UV, ZnO-NPs/H2O2/UV, and ZnO-NPs/UV. Our results indicate that the combination of both UV illumination and the ZnO-NP as a catalyst was necessary for the efficient degradation of the drug. Nearly complete removal of SERT (98.7%) was achieved in 30 min with the ZnO-NPs/UV process at room temperature. The photodegradation of SERT follows first-order kinetics with a rate constant of 0.0678 min−1. The results reveal that SERT degradation with ZnO-NPs/UV is pH-dependent, as the maximum drug removal was achieved at pH 11. Initial drug concentration, catalyst dose, and hydrogen peroxide concentration were also crucial in the removal of SERT. Our findings indicate that the high specific surface area and porous structure of ZnO-NP enhance its photocatalytic performance toward photodegradation of SERT, i.e., ZnO-NP is an efficient nanophotocatalyst for the degradation of SERT under UV irradiation.
1 January 2025 in International Journal of Analytical Chemistry
In this study, the establishment and validation of a stable reversed‐phase high‐performance liquid chromatography (RP‐HPLC) method for the concomitant estimation of the two drugs in dosage forms are presented. Method optimization was achieved by response surface methodology (RSM) using Design Expert Software 13, taking into account the special physicochemical characteristics of metoclopramide (MET) (a moderately polar molecule, pKa 9.5) and camylofin (CAM) (a less polar, hydrophobic molecule, pKa 8.7). Chromatographic resolution was achieved on a phenyl‐hexyl column under isocratic mobile phase mode in which methanol and 20 mM ammonium acetate buffer (pH 3.5) were used to provide maximum analyte interaction and resolution. The method was found to have good linearity for both analytes ( R2 > 0.999) over the concentration ranges studied. Limits of detection were 0.23 and 0.15 μg/mL for MET and CAM, respectively, and corresponding limits of quantification were 0.35 and 0.42 μg/mL, respectively. Recovery tests gave high precision values of 98.2%–101.5%, while intra‐ and inter‐day precision in relative standard deviation (RSD) was below 2%. The method was effectively applied for the analysis of commercial tablet formulations, confirming its reliability and suitability for routine quality control and regulatory analyses. Overall, the validated RP‐HPLC method provides a sensitive, accurate, and efficient means of simultaneous determination of MET and CAM in pharmaceutical dosage forms.
26 June 2026 in Journal of the Electrochemical Society
This work describes the fabrication of a reduced graphene oxide-modified screen-printed electrode (rGO-SPE) and its application as a low-cost electrochemical sensor for the determination of Darunavir concentration. This sensor can be fabricated using a screen-printing method and optimized droplet casting, and its modified surface can be characterized using Scanning Electron Microscopy, FTIR, Raman, and EIS techniques. Electrochemical analysis showed that DRV undergoes a two-electron irreversible oxidation under diffusion-controlled conditions, with a peak at pH 8.0. Under optimal conditions for differential pulls, a rGO-SPE with a broad linear dynamic range (41–1351 ng ml −1 ) and a very low limit of detection (12 ng ml −1 ) was developed. Additionally, rGO-SPE has demonstrated high precision (RSD ≤ 1.55%) and strong selectivity towards commonly encountered biological and pharmaceutical interferents. Efficiently used with pharmaceuticals and biological fluids, this rGO-SPE has emerged as a highly competent, portable alternative to traditional chromatography-based systems for clinical and pharmaceutical applications and analysis.
4 September 2026 in Journal of the Indian Chemical Society